Company Filing History:
Years Active: 2013
Title: Kevin Polach: Innovator in RNA Delivery Technologies
Introduction
Kevin Polach is a notable inventor based in Huntsville, AL (US). He has made significant contributions to the field of biotechnology, particularly in the delivery of biologically active RNA molecules. His innovative work has the potential to impact various medical applications, including gene therapy and disease treatment.
Latest Patents
Kevin Polach holds a patent for "Compositions and methods for the delivery of biologically active RNAs." This invention provides novel compounds, compositions, and methods for delivering biologically active RNA molecules to cells. The patent outlines the use of nucleic acid molecules, polypeptides, and RNA-protein complexes to facilitate this delivery. Additionally, it includes vectors for expressing polynucleotides and methods for producing these compounds and vectors. The applications of this invention are vast, as it can modulate target gene expression for diagnosing, preventing, and treating various diseases.
Career Highlights
Kevin Polach is currently associated with Egen, Inc., where he continues to advance his research in RNA delivery technologies. His work is characterized by a commitment to innovation and a focus on practical applications that can benefit healthcare.
Collaborations
Some of Kevin's coworkers include Jason Fewell and Khursheed Anwer, who contribute to the collaborative environment at Egen, Inc. Their combined expertise fosters a dynamic approach to research and development in the field.
Conclusion
Kevin Polach's contributions to RNA delivery technologies exemplify the intersection of innovation and biotechnology. His patent and ongoing work at Egen, Inc. highlight the importance of advancing methods for effective gene therapy and disease treatment.